Caring Today for a Healthier Tomorrow and Forever Find A Doctor
Caring Today for a Healthier Tomorrow and Forever Find A Doctor
Jamia Nagar Okhla, New Delhi – 110025
Jamia Nagar Okhla, New Delhi – 110025
Liver cancer, also known as hepatic cancer, arises either in the liver cells (primary) or spreads from other organs (secondary or metastatic liver cancer). The most common form is hepatocellular carcinoma (HCC), which often occurs in people with chronic liver disease, hepatitis B or C, or cirrhosis.
India has positioned itself as a global center for liver cancer treatment, offering world-class medical care combined with cost-effective treatment options. With experienced surgical oncologists, hepatologists, and liver transplant teams, Indian hospitals provide a full spectrum of services—from early-stage diagnosis to complex surgeries and advanced therapies—all under one roof.
India’s leading cancer hospitals are equipped to treat various forms of liver cancer, including:
Hepatocellular Carcinoma (HCC) – Most common type of primary liver cancer
Cholangiocarcinoma – Cancer of the bile ducts (intrahepatic or extrahepatic)
Hepatoblastoma – A rare liver cancer in children
Angiosarcoma and Hemangiosarcoma – Rare, fast-growing cancers of liver blood vessels
Secondary Liver Cancer (Metastatic) – Liver cancer spread from other organs like colon, breast, or pancreas
Over 40,000 new liver cancer cases are diagnosed annually in India.
Globally, liver cancer is the sixth most common cancer and the third leading cause of cancer-related death.
India has seen a significant rise in HCC, particularly among patients with hepatitis C and fatty liver disease.
Increasing awareness and availability of advanced treatment in India have led to improved survival outcomes.
A precise diagnosis is crucial to determine treatment eligibility. Indian hospitals utilize advanced diagnostic protocols, including:
Liver Function Tests (LFTs)
Alpha-Fetoprotein (AFP) Test
Ultrasound & Contrast-Enhanced CT Scan
MRI of the Liver
Liver Biopsy (when needed)
PET-CT for staging and assessing metastasis
FibroScan to assess liver stiffness in cirrhosis cases
These tests help oncologists determine the type, stage, and operability of the cancer.
Surgical Resection: Surgical resection is one of the most effective treatment options for liver cancer, particularly in cases where the tumor is localized and the liver function is preserved. It involves removing the cancerous portion of the liver while leaving healthy tissue intact. This surgery is ideally suited for early-stage hepatocellular carcinoma (HCC) and can be performed using either an open surgical method or a minimally invasive laparoscopic technique. Laparoscopic surgery offers faster recovery, smaller incisions, and less postoperative pain. Indian hospitals are equipped with advanced surgical infrastructure and experienced hepatobiliary surgeons, ensuring high standards of safety, real-time intraoperative monitoring, and enhanced postoperative care in dedicated liver units.
Liver Transplantation: Liver transplantation is considered a curative option for patients with liver cancer who have small tumors and underlying liver disease such as cirrhosis. This procedure replaces the diseased liver with a healthy one from a living or deceased donor. In India, both types of liver transplants are available, with living-donor transplants being more common due to organ availability. These procedures are conducted at NABH-accredited transplant centers with HEPA-filtered ICUs, which significantly reduce the risk of infections and improve outcomes. With advanced surgical teams, skilled transplant coordinators, and cost-effective transplant packages, India has become a preferred destination for liver transplant surgeries among international patients.
Ablation Therapies: Ablation therapies, including Radiofrequency Ablation (RFA) and Microwave Ablation (MWA), are non-surgical treatment options used to destroy liver tumors using heat. These procedures are typically performed under ultrasound or CT guidance by interventional radiologists. A thin probe is inserted into the tumor, and thermal energy is applied to ablate the cancerous cells. Ablation therapies are most effective for patients with small tumors (less than 3 cm) who are not suitable candidates for surgery or transplant. These techniques are less invasive, involve minimal hospital stays, and have a quicker recovery time, making them an ideal choice for early-stage or unresectable liver cancer cases.
Transarterial Chemoembolization (TACE): Transarterial Chemoembolization (TACE) is a minimally invasive procedure used mainly for patients with intermediate-stage liver cancer or those who are ineligible for surgical interventions. In this technique, a catheter is guided into the hepatic artery—the main blood supply to the liver—and chemotherapy drugs are delivered directly to the tumor. At the same time, the artery is blocked (embolized), which starves the tumor of oxygen and nutrients. This dual-action approach enhances the effectiveness of chemotherapy while limiting its systemic side effects. TACE is widely available in India and is often used as a bridging therapy before transplant or to control tumor growth in unresectable cases.
Targeted Therapy: Targeted therapy is a systemic treatment that focuses on blocking the specific molecules or pathways that promote cancer growth. In liver cancer, drugs such as Sorafenib, Lenvatinib, and Regorafenib are commonly used to halt tumor progression. These medications are usually prescribed for advanced or inoperable cases and can help stabilize the disease for extended periods. Indian hospitals provide access to both international and generic formulations of these drugs at significantly lower costs compared to Western countries. Treatment is often delivered in outpatient settings, and patients are regularly monitored through imaging and blood tests to assess effectiveness and manage side effects.
Immunotherapy: Immunotherapy is an advanced treatment approach that harnesses the power of the body’s immune system to recognize and attack cancer cells. In India, immune checkpoint inhibitors such as Atezolizumab in combination with Bevacizumab have shown promising results in patients with advanced or unresectable hepatocellular carcinoma. These therapies are typically used when targeted therapies are no longer effective or as part of combination treatment strategies. Administered through intravenous infusions under close supervision, immunotherapy is currently available at leading tertiary cancer centers in India. It is tailored to patient-specific conditions and may offer improved survival outcomes for select individuals.
Radiation Therapy: While not the frontline treatment for most liver cancers, radiation therapy plays an important role in specific scenarios such as bile duct cancer (cholangiocarcinoma), metastatic liver cancer, or palliative care to relieve symptoms. India offers cutting-edge radiation technologies, including Stereotactic Body Radiotherapy (SBRT), Intensity-Modulated Radiotherapy (IMRT), and CyberKnife. These techniques allow high-precision targeting of liver tumors while sparing healthy liver tissue, reducing the risk of radiation-related side effects. Radiation may be used as a standalone treatment or in combination with other therapies like TACE or chemotherapy, particularly when surgery is not an option.
Step 1: Remote Evaluation
Submit reports for review. The medical team shares a treatment plan and estimate.
Step 2: Arrival & Preoperative Testing
Additional blood tests, liver imaging, and fitness evaluations are conducted.
Step 3: Treatment Initiation
Depending on the diagnosis, surgery, transplant, or systemic therapy is started.
Step 4: Monitoring & Response Evaluation
AFP levels and imaging are used to track tumor response and disease progression.
Step 5: Post-Treatment Follow-Up
Includes dietary guidance, liver care, and infection control, especially post-transplant.
|
Treatment Type |
Hospital Stay |
Full Recovery |
|
Liver Resection Surgery |
5–7 days |
3–6 weeks |
|
Liver Transplant |
2–3 weeks |
3–6 months |
|
TACE or RFA (Daycare) |
1–2 days |
1–2 weeks |
|
Systemic Therapy (OPD) |
Outpatient basis |
Ongoing monitoring |
Recovery varies based on liver function, cancer stage, and overall health condition.
|
Treatment Type |
Estimated Cost (INR) |
Estimated Cost (USD) |
|
Liver Resection Surgery |
₹3,00,000 – ₹5,00,000 |
$3,600 – $6,000 |
|
Liver Transplant |
₹18,00,000 – ₹30,00,000 |
$22,000 – $36,000 |
|
TACE / RFA per session |
₹1,50,000 – ₹2,50,000 |
$1,800 – $3,000 |
|
Targeted Therapy (monthly) |
₹80,000 – ₹2,00,000 |
$960 – $2,400 |
|
Immunotherapy (monthly) |
₹2,50,000 – ₹4,50,000 |
$3,000 – $5,400 |
India offers savings of up to 70% compared to global liver cancer treatment costs.
Renowned Hepato-Oncology Centers with liver transplant facilities
Globally Trained Liver Surgeons & Oncologists
Access to Complex Procedures like TACE, RFA, and robotic liver surgery
World-Class Infrastructure including NABH & JCI-accredited hospitals
Affordable Pricing & Transparent Packages
Short Wait Times & Fast-Track Treatment Planning
Full Medical Tourism Support: Visa, accommodation, interpreters
Liver Resection (Early-Stage HCC): 70–85% 5-year survival rate
Liver Transplant (within Milan Criteria): 85–90% survival after 5 years
TACE / RFA (Intermediate Stage): 60–70% disease control for 1–2 years
Targeted Therapy (Advanced HCC): Stabilization in 40–50% of patients
Outcomes depend on early diagnosis, liver function, cancer stage, and treatment access.
India offers a comprehensive and cost-effective approach to liver cancer treatment, supported by cutting-edge technology, skilled specialists, and internationally benchmarked protocols. Whether it’s surgical resection, liver transplant, TACE, or immunotherapy, Indian hospitals are equipped to deliver world-class outcomes at significantly lower costs. For patients seeking timely, advanced, and holistic cancer care, India stands out as a destination of hope, healing, and high success.
1. Can international patients receive liver cancer treatment in India?
Yes. India is a leading destination for liver cancer and liver transplant services with full support for foreign patients.
2. Is liver transplant a cure for liver cancer?
In eligible patients with early HCC and no spread, liver transplant can be curative.
3. What is the best treatment for liver cancer?
It depends on tumor size, stage, and liver function. Options range from surgery to systemic therapy.
4. Are Indian hospitals safe for liver transplant?
Yes. Major centers follow international safety standards and infection control protocols.
5. How long does it take to get a liver transplant in India?
With a living donor, the transplant can be scheduled quickly. Deceased donor wait times vary.
6. Is treatment in India affordable compared to Western countries?
Yes. You can expect 60–70% cost savings with equivalent success outcomes.
7. Will I need follow-up care after returning home?
Yes. Indian hospitals offer remote consultations, medication guidance, and imaging review post-discharge.
8. Are there long-term side effects of treatment?
Liver damage, fatigue, or side effects from drugs may occur, but they are closely monitored and managed.
9. Can liver cancer be detected early?
Screening with AFP and ultrasound is useful in high-risk patients (hepatitis, cirrhosis).
10. Are alternative therapies available?
Some centers offer integrative care including dietary counseling, yoga, and stress management.